CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs Drug-Drug Interactions of Common Cardiac Medications and Chemotherapeutic Agents Alcohol consumption, cardiac biomarkers, and risk of atrial fibrillation and adverse outcomes Cardio-Oncology Services: rationale, organization, and implementation: A report from the ESC Cardio-Oncology council Endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity may be therapeutically targeted by natural and chemical compounds: A review Systematic Review and Network Meta‐Analysis Comparing Bifurcation Techniques for Percutaneous Coronary Intervention Transseptal puncture versus patent foramen ovale or atrial septal defect access for left atrial appendage closure

ConsensusVolume 76, Issue 5, August 2020

JOURNAL:J Am Coll Cardiol. Article Link

2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants: A Report of the American College of Cardiology Solution Set Oversight Committee

GF Tomaselli, KW Mahaffey, A Cuker et al. Keywords: ACC Expert Consensus Decision Pathway; apixaban; atrial fibrillation; betrixaban; dabigatran; edoxaban; rivaroxaban; venous thromboembolism; warfarin

Full Text PDF